tirzepatide summit trial SUMMIT: a 'Huge Win' for HFpEF Patients With Obesity Tirzepatide vs Semaglutide 2026: 22%

25 mg/kg IP for 15 days increased treadmill endurance

Its like getting bonus health benefits from a single treatment

Stress and poor sleep High caffeine intake or energy drinks Excessive alcohol use or withdrawal Smoking or nicotine products Physical inactivity Use of stimulants or illicit drugs such as cocaine or methamphetamine Dehydration These behaviors can magnify palpitations or tachycardia and increase the likelihood of symptoms appearing

The next decade will likely witness a paradigm shift in MASLD management, driven by incretin-based therapies and other innovative therapies that target the disease at its metabolic core

Less interest in sweets